Sentences with phrase «of access to vaccines»

Not exact matches

«The global community will rightly expect the pace — alongside a high level of diligence — to be maintained so that people in affected communities and others living in countries at risk of Ebola can have access to a vaccine as soon as possible.»

China now has numerous life science companies that serve its domestic market, providing greater access to medical products and facilitating the development of the country's first WHO - prequalified vaccine.

Raising organic meat is far more than just making sure animals are free ranging and grass fed, it's equally about producing cattle without synthetic growth hormones, limiting vaccine use, not using routine antibiotics, breeding using natural methods, stress free weaning that allows for the ethological needs of mothers and young, access at all times to unfiltered sunlight and not using electric prodders as a routine management method.

Thousands of deaths could be averted through a combined prevention and treatment strategy — interventions such as improved mother and child nutrition, optimal breastfeeding practices; Oral Rehydration Therapy [ORT]; new low - osmolarity formulations of ORS; incorporating rotavirus vaccines; zinc supplementation during diarrhoea episodes; immunizing all children against measles; appropriate drug therapy; increased access to safe clean water and sanitation facilities and improved personal and domestic hygiene, including keeping food and water clean and washing hands before touching food.

Cuomo today signed an executive order to combat the flu epidemic in New York, allowing pharmacists to administer flu vaccines to children ages 2 to 18 to increase access and convenience for those seeking the vaccine as the number of reported cases across the state continues to rise.

«I ask all New Yorkers to take advantage of this expanded access to flu vaccines and join us in slowing down and stopping the spread of this virus in the Empire State.»

The GAVI Alliance (formerly known as the Global Alliance for Vaccines and Immunization) has been in existence since 2000 and seeks to «align public and private resources in a global effort to create greater access to the benefits of immunization.»

This same lack of health care access makes poor children who are under - vaccinated potentially more vulnerable to health risks as rates of vaccine - preventable diseases continue to rise.

Global access to vaccines has been improving, now reaching close to 90 percent in some parts of the developing world, says Michel Zaffran, deputy secretary for the Global Alliance for Vaccines and Immunization (GAVI Alliance), an aid group that works to improve global vaccine coverage and helped develop the pivaccines has been improving, now reaching close to 90 percent in some parts of the developing world, says Michel Zaffran, deputy secretary for the Global Alliance for Vaccines and Immunization (GAVI Alliance), an aid group that works to improve global vaccine coverage and helped develop the piVaccines and Immunization (GAVI Alliance), an aid group that works to improve global vaccine coverage and helped develop the pilot AMC.

More important, food vaccines might save millions who now die for lack of access to traditional inoculants

«Doing so depends not on the delivery of a single intervention, like vaccines, bed nets and cocktails of medicine, but on a well - functioning health system, with access to skilled birth attendants and emergency obstetric care.»

Seasonal flu vaccines may protect individuals not only against the strains of flu they contain but also against many additional types, according to a study published this week in mBio ®, the online open - access journal of the American Society for Microbiology.

The Institute of Medicine concluded last May that no claim could be made for a causal link between mercury - laced vaccines and autism, but several independent researchers had complained that their access to federal vaccine databases, which could provide evidence of a link, had been repeatedly blocked.

Bianco notes that the placement of the institute in India brings several benefits, including a rich scientific base, and access to Indian firms with expertise in making affordable drugs and vaccines and to a large population of lower - income people who could test new vaccines and would be among the immediate beneficiaries of any successes.

The government provides subsidized livestock that covers 13 % of the farmers» annual needs, as well as free medicine and vaccines for their animals as well as access to protected pastures.

IDMIT will contribute 1) To the development and validation of assays based on flow cytometry and mass cytometry for the evaluation of immune responses in humans and animal models; these tools will be particularly relevant for the identification of signatures of vaccine efficacy; 2) To the animal model platform, in particularly by providing access to NHP models and to new technologies for in vivo imaging infections and host responses; 3) To networking activities, in particular by organising a workshop on in vivo imaginTo the development and validation of assays based on flow cytometry and mass cytometry for the evaluation of immune responses in humans and animal models; these tools will be particularly relevant for the identification of signatures of vaccine efficacy; 2) To the animal model platform, in particularly by providing access to NHP models and to new technologies for in vivo imaging infections and host responses; 3) To networking activities, in particular by organising a workshop on in vivo imaginTo the animal model platform, in particularly by providing access to NHP models and to new technologies for in vivo imaging infections and host responses; 3) To networking activities, in particular by organising a workshop on in vivo imaginto NHP models and to new technologies for in vivo imaging infections and host responses; 3) To networking activities, in particular by organising a workshop on in vivo imaginto new technologies for in vivo imaging infections and host responses; 3) To networking activities, in particular by organising a workshop on in vivo imaginTo networking activities, in particular by organising a workshop on in vivo imaging.

The Vaccine Formulation Institute has access to laboratories and training facilities, including at University of Lausanne, Switzerland.

Even those groups with access to suitable adjuvants frequently fail in the development of their adjuvanted vaccines because of a lack of knowledge on how to correctly formulate and characterize both their adjuvants and the resulting vaccine formulations.

TNA8: BPRC will provide access to macaques for immunogenicity / adjuvanticity evaluation of vaccine candidates for malaria, tuberculosis, HIV, influenza, West Nile virus or dengue virus, with up to three (prime - boost) immunisation events.

The Fraunhofer IME leads the Transnational Access 1 (TNA1) «Cross platform screening and optimization service «and the corresponding Joint Research Activity (JRA1) «Improved optimization and harmonization of cross-vector screening «both aiming at the provision of comprehensive range of different well established pro- and eukaryotic expression / production systems to identify the optimal manufacturing platform for any given vaccine candidate.

In the face of shortage, or differential access, genetic information could be used to make triage decisions or decide who receives a vaccine or therapy.

Specifically, 1 unit of access comprising a vaccination / challenge study with 3 groups of 6 ferrets (control and 2 vaccine groups), to include vaccination / boost, intra-nasal challenge with influenza virus, monitoring of virus load (nasal washes), disease progression and immune responses (antibody, IFN gamma ELISA and ELISpot).

Often, the knowledge on how to access, down - select, and formulate adjuvants is not readily available to the majority of vaccine research groups.

In order to facilitate access to these skills and capacities, and to promote collaborations in the European vaccine landscape - aiming thereby to accelerate the development of safe, effective and affordable vaccines - the EC, in the context of the Horizon 2020 Framework Programme, has recently funded «TRANSVAC2», a European vaccine research and development (R&D) infrastructure.

Today UNIL - VFL provides access to adjuvants, adjuvant quality control technology, adjuvant formulation expertise, technology transfer, training, and bespoke adjuvant R&D services, allowing partners to gain optimal benefit from the use of adjuvants and vaccine formulation technology.

iBET's infrastructure comprises 16 laboratories fully equipped with state - of - the - art technology (70 m2 each), including a BSL2 laboratory for working with viruses; a GMP Analytical Services Unit certified by the INFARMED (the Portuguese medicines authority, EMA Portuguese branch) and by DGAV (the Portuguese veterinary authority) for quality control and batch release of human and veterinary pharmaceuticals, biopharmaceuticals as well as experimental new drugs; a GMP Mass - Spectroscopy Unit that provides state - of - the - art MS services to the scientific community and Industry; a 2600 m2 bio-pilot plant supporting production and purification of proteins ATMPs and vaccines from bench top to 300 L scale and privileged access to GeniBET Biopharmaceuticals, an iBET spin - off producing ATMPs under cGMP certification for phase I / II / III clinical trials.

Through strategic partnerships with industry and nonprofit organizations, we gain access to a portfolio of priority drugs for testing within our expert focus groups, including checkpoint inhibitors, therapeutic vaccines, innate immune stimulants, targeted therapies, and many other promising treatments and technologies with high therapeutic potential.

The Transnational Access 1 (TNA1) «Cross platform screening and optimization service «and the corresponding Joint Research Activity (JRA1) «Improved optimization and harmonization of cross-vector screening «will combine the expertise of six different partners (IME, SSI, UOXF, iBET, BPRC and UNISI) to provide the unique offer to test vaccine candidates in a comprehensive range of different expression hosts, to identify the optimal production system for further pre-clinical and clinical development.

As part of its work package 8 activities, UNIL - VFL is providing access to the expertise within its dedicated facility for adjuvant supply, vaccine formulation, and quality control of adjuvanted vaccines, so as to accelerate the optimisation and characterisation of stable and effective formulations.

A shotgun genome sequencing project was undertaken in the expectation that access to the complete protein coding repertoire of the organism will facilitate the search for vaccine candidate genes.

Recognizing that communicable diseases and neglected tropical diseases disproportionately affect countries with evolving healthcare systems, Takeda is collaborating with partners to expedite access to its potentially life - saving vaccine candidates, which address some of today's most challenging infectious diseases.

The HERMES Logistics Modeling Team, consisting of researchers from Pittsburgh Supercomputing Center (PSC) and the Johns Hopkins Bloomberg School of Public Health and International Vaccine Access Center (IVAC), have used HERMES, their public health product supply chain modeling software, to help the Republic of Benin in West Africa determine how to bring more lifesaving vaccines to its children.

Within the framework of TRANSVAC2, the HZI will offer access in the form of pre-clinical studies in the murine system to assess the immunogenicity, safety and efficacy of specific vaccine formulations.

As partner of TRANSVAC, IRTA will provide access to their animal facilities (CReSA) to carry out safety and immunogenicity studies of new candidate vaccines and / or of novel vaccination (administration) strategies in pigs, ferrets and other large animal species.

Access to clean water, modern sanitation, efficient insect control, and the advent of effective vaccines to target childhood disease may have made us complacent.

Access to improved water sources have reduced disease incidence in parts of the world but the use of efficacious vaccines is seen as an important public health tool for countries with a high disease burden.

The unit of access comprises a vaccination / challenge study with 3 groups of 6 ferrets (control and 2 vaccine groups), to include intra-nasal challenge with influenza virus, monitoring of virus load (nasal washes), disease progression and immune responses (antibody, IFN gamma ELISA and ELISpot).

The access includes animal breeding, housing, caretaking and biotechnical expertise for mouse studies on a vaccine candidate (provided by the user) including sampling and standard immune monitoring to carry out validation experiments of the new vaccine candidate or vaccination strategies of the potential user.

As partner of TRANSVAC2, WBVR will provide access to their animal facilities (Lelystad) to carry out immunogenicity and efficacy studies of new candidate vaccines and / or of novel vaccination (administration) strategies in pigs, cattle, ferrets or other animal species.

Within the framework of TRANSVAC2, the HZI will offer access in the form of pre-clinical studies in the murine system to assess the immunogenicity, safety and efficacy of specific vaccine formulations containing a mucosal adjuvant.

She has been active legislatively, playing a leading role in defeating the extension of a vaccine - tracking registry in Idaho and helping to secure legislation protecting consumer access to raw milk.

Vaccine blood titers are another way of accessing your pets immunity to disease, and need for vaccines.

We work closely with the City of Austin and the City of Houston to ensure that pet owners in the most low - income areas have access to the vet care they need — especially spay / neuter and vaccines.

Groups like Willamette Humane Society in Salem, OR, offer experiences tailored to puppies not yet through their full round of vaccines: they're carried from the car to a carefully - cleaned training room, and have designated potty spaces other dogs can't access.

Dr. Dodds feels the holistic veterinary community needs to document more case studies of adverse reactions and do cohort reports so that DVMs have access to information about predisposing factors that increase vaccine risks for certain pets.

Restricting mobile vaccine services will likely cause pets to die because the preventative services that could have been received from our mobile vaccine service will be limited, eliminating access to care for a significant amount of individuals and overtime, leading to the deaths of many pets that have contracted preventable, but deadly illnesses.

For the poorest, more expensive energy reduces their access to energy - driven services like increased use of fertilizer, vaccine refrigeration, reasonable transportation, and many other things that can improve the conditions in which they live.

«Planned Parenthood is working hard to ensure that comprehensive access to cancer screenings, condoms, and the HPV vaccine are part of our public health priorities in 2008.»

Promoting flu vaccine to everyone is important, as is providing ease of access, awareness and opportunity.